IMMUNOLIFE, a Phase 2 randomized exploratory study, will evaluate the potential of MaaT033 in combination with Cemiplimab ...

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, will ...

Cox, Castle & Nicholson LLP, a leading full-service law firm specializing in real estate in the United States, announced ...

Genentech will more than double the initial investment in a state-of-the-art biomanufacturing facility in Holly Springs to approximately $2 billion, bolstering Roche and Genentech’s $50 billion ...

Following discussions with the U.S. FDA, the Agency recommended that the Company submit additional information for its ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth quarter and full year 2025 financial results on Thursday, February 12, 2026, after the financial markets close. The company ...

Agreement comes on the heels of Company inking an exclusive distribution agreement with Gulf Medical for Saudi ArabiaCreates ...

Presentation will Cover Recent Corporate Milestones Including Acceleration of Manufacturing Readiness for Entolimod™ FREMONT, CA / ACCESS Newswire / January 20, 2026 / Tivic Health® Systems, Inc.

Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced that its San ...

OPEX® Corporation, a global leader in Next Generation Automation providing innovative solutions for warehouse, document and ...

Davos: Investing in small scale farmers and rural entrepreneurs is a compelling business case and a geostrategic ...

Oral presentation to highlight first-ever clinical evidence supporting use of a targeted GYS1 substrate reduction therapy, ...